Related Experiment Video
Updated: Sep 14, 2026
Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution
Published on: February 24, 2015
[Study on Methylation of p15(INK4B) Gene in Acute Myeloid Leukemia and Chronic Myeloid Leukemia]
Xiuzhi Guo1, Hongtao Fan, Qiong Wu
1Department of Hematology, Jinan University Medical School, Guangzhou 510632, China; Howard University, USA Department of Biochemistry, The First Military Medical University, Guangzhou 510515, China; Department of Hematotolgy, The First Affiliated Hospital, Jinan Univesity Medical School, Guangzhou 510632, China; Department of Hematology, Liuhuaqiao Hospital, Guangzhou 510010, China.
Abstract:
In order to explore the role of p15(INK4B) gene with highly methylated CpG island in the pathogenesis of leukemia, the expression levels of p15(INK4B) gene was detected in patients with AML and CML. Methylation-specific PCR (MSP) assay was employed in the experiments. The methylation incidence was 83.9% (26/31) in AML and 0% (0/28) in CML. The results showed that methylation of p15(INK4B) gene was the one of the major ways for inactivation of the gene, and the methylation could be appeared in clinical development of the disease and patients condition worsened. Methylation of p15(INK4B) did not occur and its function probably is normal in CML.
Insights
Methylation of the p15(INK4B) gene is common in acute myeloid leukemia (AML), leading to gene inactivation. This methylation was not observed in chronic myeloid leukemia (CML), suggesting normal p15(INK4B) function in CML.
Area of Science:
- Molecular biology
- Oncology
- Genetics
Background:
- The p15(INK4B) gene plays a crucial role in cell cycle regulation.
- Aberrant methylation of CpG islands is implicated in various cancers, including leukemia.
- Understanding gene inactivation mechanisms is vital for leukemia pathogenesis research.
Purpose of the Study:
- To investigate the role of p15(INK4B) gene methylation in the pathogenesis of acute myeloid leukemia (AML) and chronic myeloid leukemia (CML).
- To determine the correlation between p15(INK4B) gene methylation status and disease progression in leukemia patients.
Main Methods:
- Detection of p15(INK4B) gene expression levels in AML and CML patient samples.
- Utilizing methylation-specific PCR (MSP) assay to assess CpG island methylation status.
- Correlation analysis between methylation incidence and clinical parameters.
Main Results:
- High methylation incidence of the p15(INK4B) gene (83.9%) was observed in AML patients.
- No methylation of p15(INK4B) was detected in CML patients (0%).
- p15(INK4B) gene methylation was identified as a significant mechanism for gene inactivation, particularly in advanced AML stages.
Conclusions:
- Methylation-driven inactivation of the p15(INK4B) gene is a key event in AML pathogenesis.
- The absence of p15(INK4B) methylation in CML suggests its functional integrity in this leukemia subtype.
- These findings highlight differential epigenetic regulation of p15(INK4B) in distinct leukemia types.
